Evotec AG announced today a research collaboration and licensing deal with Debiopharm GroupTM Lausanne, Switzerland. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-and-debiopharm-grouptm-to-collaborate-on-development-of-new-treatment-for-cancer-5201